BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.

MLA

Rossi, Giulio, et al. “BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.” Journal of Personalized Medicine, vol. 14, no. 4, Apr. 2024, p. 394. EBSCOhost, https://doi.org/10.3390/jpm14040394.

APA

Rossi, G., Righi, L., Barbisan, F., Tiseo, M., Spagnolo, P., Grosso, F., Pisapia, P., Malapelle, U., Sculco, M., Dianzani, I., Abate-Daga, L., Davolio, M. C., Ceresoli, G. L., Galetta, D., Pasello, G., Novello, S., & Bironzo, P. (2024). BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. Journal of Personalized Medicine, 14(4), 394. https://doi.org/10.3390/jpm14040394

Chicago

Rossi, Giulio, Luisella Righi, Francesca Barbisan, Marcello Tiseo, Paolo Spagnolo, Federica Grosso, Pasquale Pisapia, et al. 2024. “BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.” Journal of Personalized Medicine 14 (4): 394. doi:10.3390/jpm14040394.